BTIG Reiterates Buy on BrainsWay, Maintains $20 Price Target
BTIG analyst Sam Eiber reiterates BrainsWay (NASDAQ:BWAY) with a Buy and maintains $20 price target.
Stocks · News reference
BrainsWay Raises FY2026 Sales Guidance from $66.000M-$68.000M to $68.000M-$70.000M vs $67.819M Est
BrainsWay (NASDAQ:BWAY) raises FY2026 sales outlook from $66.000 million-$68.000 million to $68.000 million-$70.000 million vs $67.819 million estimate.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
HC Wainwright & Co. Reiterates Buy on BrainsWay, Maintains $19 Price Target
Snowflake To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. BMO Capital cut the price
HC Wainwright & Co. Maintains Buy on BrainsWay, Raises Price Target to $19